Form 4 for NHC NATIONAL HEALTHCARE CORP
Accepted 2022-05-06 00:00:00 ET · period of report 2022-05-05 · accession 0001437749-22-011337 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-05-06 | 2022-05-05 | NHC | LAROCHE RICHARD F JR | Dir | M - OptEx | $63.27 | +5,000 | 194.3K | +3% | +$316.4K |
| DM | 2022-05-06 | 2022-05-05 | NHC | LAROCHE RICHARD F JR | Dir | M - OptEx | $0.00 | -5,000 | 5,000 | -50% | $0 |
| D | 2022-05-06 | 2022-05-05 | NHC | LAROCHE RICHARD F JR | Dir | A - Grant | $0.00 | +7,500 | 7,500 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock - Held in my name or my wife's name | 2022-05-05 | M | A | 2,500 | $61.90 | 0 | D | — | — | (F1) These stock options were granted pursuant to the 2010 Omnibus Equity Incentive Plan on May 3, 2018. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). (F2) Transactions for this "Title of Security" totaled on the line below. |
| 2 | Common | Common Stock - Held in my name or my wife's name | 2022-05-05 | M | A | 2,500 | $64.64 | 194,313 | D | — | — | (F3) These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on May 7, 2020. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). (F4) Total amount of shares beneficially owned following transactions reported for this "Title of Securities" on this form. |
| 3 | Derivative | Option to Purchase Common Stock | 2022-05-05 | M | D | 2,500 | $0.00 | 0 | D | $61.90 · 2018-05-03 to 2023-05-02 | 2,500 Common Stock | |
| 4 | Derivative | Option to Purchase Common Stock | 2022-05-05 | M | D | 2,500 | $0.00 | 5,000 | D | $64.64 · 2021-05-07 to 2025-05-06 | 7,500 Common Stock | |
| 5 | Derivative | Option to Purchase Common Stock [2022 Grant] | 2022-05-05 | A | A | 7,500 | $0.00 | 7,500 | D | $69.19 · 2023-05-05 to 2027-05-04 | 7,500 Common Stock | (F5) These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on May 5, 2022. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). |